Drug
Qilisheng Immunoregulatory Oral Solution clinical trials
How studies write it
Studies that test it under each name
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 6
Studies
Open first, then newest update. How each study uses Qilisheng Immunoregulatory Oral Solution is read from its arms, and is right about nine times in ten.
Testing it · 6
- Bioinformation Therapy for Liver CancerCompletedPhase 2/3Fuda Cancer Hospital, GuangzhouNCT03239158Written as Life information rehabilitation therapy
- Bioinformation Therapy for Breast CancerCompletedPhase 2/3Fuda Cancer Hospital, GuangzhouNCT03240224Written as Life information rehabilitation therapy
- Bioinformation Therapy for Intestinal CancerCompletedPhase 2/3Fuda Cancer Hospital, GuangzhouNCT03350490Written as Life information rehabilitation therapy
- Bioinformation Therapy for Pancreatic CancerCompletedPhase 2/3Fuda Cancer Hospital, GuangzhouNCT03239184Written as Life information rehabilitation therapy
- Bioinformation Therapy for Lung CancerCompletedPhase 2/3Fuda Cancer Hospital, GuangzhouNCT03239171Written as Life information rehabilitation therapy
- Bioinformation Therapy for Gastric CancerCompletedPhase 2/3Fuda Cancer Hospital, GuangzhouNCT03350477Written as Life information rehabilitation therapy